I. Boyd

发表

Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw.

Dennis P. West, Robert E. Marx, Jayesh Mehta, 2008, The Lancet. Oncology.

Hyponatraemia due to the combination of hydrochlorothiazide and amiloride (Moduretic): Australian spontaneous reports 1977‐1988

T. Mathew, I. Boyd, A. Rohan, 1990, The Medical journal of Australia.

A study of codispensing with sodium alendronate in Australia.

I. Boyd, J. McEwen, L. Calcino, 2006, British journal of clinical pharmacology.

Postmarketing surveillance: strengths and limitations. The flucloxacillin–dicloxacillin story

I. Boyd, 1999, The Medical journal of Australia.

Hypertension with moclobemide

I. Boyd, 1995, The Lancet.

The role of the Australian Adverse Drug Reactions Advisory Committee (ADRAC) in monitoring drug safety.

I. Boyd, 2002, Toxicology.

Co‐Dispensing of Contraindicated Drugs with Cisapride

I. Boyd, J. McEwen, R. Walsh, 2008 .

The next twenty years

H. Habermeier, H. Grimmeiss, P. Glasow, 2003, Nature materials.

Pneumonitis associated with leflunomide: a profile of New Zealand and Australian reports

J. Highton, I. Boyd, R. Savage, 2006, Internal medicine journal.

Toenails and agranulocytosis

I. Boyd, P. Pillans, 2007, Internal medicine journal.

Acute Liver Failure Due To Amoxicillin and Amoxicillin/Clavulanate

William M. Lee, R. Fontana, J. Greenson, 2005, Digestive Diseases and Sciences.

Urinary disorders associated with cisapride

I. Boyd, A. Rohan, I. Rohan, 1994 .

Cefaclor‐associated serum sickness

I. Boyd, 1998, The Medical journal of Australia.

Bisphosphonates and osteonecrosis of the jaw

P. Purcell, I. Boyd, 2005, The Medical journal of Australia.

Tramadol and seizures

I. Boyd, 2005, The Medical journal of Australia.

Comment: Hyponatremia with Venlafaxine

I. Boyd, 1998, The Annals of Pharmacotherapy.

Venlafaxine withdrawal reactions

I. Boyd, 1998, The Medical journal of Australia.

Captopril-induced taste disturbance

I. Boyd, 1993, The Lancet.

Teaching Pharmacovigilance: the WHO-ISoP Core Elements of a Comprehensive Modular Curriculum

M. Lindquist, A. Bate, I. Edwards, 2014, Drug Safety.

Risk Factors for Rhabdomyolysis with Simvastatin and Atorvastatin

I. Boyd, K. Ronaldson, J. O’Shea, 2006, Drug safety.

Mja Guidelines for Assessing Qualitative Research Quality in Qualitative Research Criteria for Authors and Assessors in the Submission and Assessment of Qualitative Research Articles for the Medical Journal of Australia

G. Andrews, I. Baguley, D. Bennett, 2022 .

The Medical Journal of Australia

G. Andrews, I. Baguley, D. Bennett, 1965 .

Sustained Decline of Direct General Practitioner Reporting of Adverse Drug Reactions in Australia and Paucity in Details of Australian Reports in Safety Advisories

I. Boyd, J. McEwen, 2023, Drug Safety.

Near‐death of Australia's Medicines Safety Update

I. Boyd, J. McEwen, 2021, Internal medicine journal.

COX‐2 inhibitors and renal failure: the triple whammy revisited

T. Mathew, I. Boyd, M. Thomas, 2000, The Medical journal of Australia.

Comment: HMG-CoA Reductase Inhibitor-Induced Impotence

I. Boyd, 1996, The Annals of Pharmacotherapy.

Erythromycin-induced hearing loss

I. Boyd, 1991, The Lancet.

Gynaecomastia in association with calcium antagonists

I. Boyd, 1994, The Medical journal of Australia.

Benign intracranial hypertension induced by minocycline

I. Boyd, 1995 .